Adcetris’s anti-CD30 antibody binds to CD30 antigen in Hodgkin disease cells and LeY antigen in cancer cells, while MMAE, the drug toxin, effectively inhibits mitosis by inhibiting tubulin polymerization. This evidence concerns the gene TNFRSF8 and cancer.